4D0X | pdb_00004d0x

Pyrrole-3-carboxamides as potent and selective JAK2 inhibitors


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.82 Å
  • R-Value Free: 
    0.219 (Depositor), 0.215 (DCC) 
  • R-Value Work: 
    0.163 (Depositor), 0.162 (DCC) 
  • R-Value Observed: 
    0.166 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 4D0X

Ligand Structure Quality Assessment 


This is version 1.6 of the entry. See complete history

Literature

Pyrrole-3-Carboxamides as Potent and Selective Jak2 Inhibitors.

Brasca, M.G.Nesi, M.Avanzi, N.Ballinari, D.Bandiera, T.Bertrand, J.Bindi, S.Canevari, G.Carenzi, D.Casero, D.Ceriani, L.Ciomei, M.Cirla, A.Colombo, M.Cribioli, S.Cristiani, C.Della Vedova, F.Fachin, G.Fasolini, M.Felder, E.R.Galvani, A.Isacchi, A.Mirizzi, D.Motto, I.Panzeri, A.Pesenti, E.Vianello, P.Gnocchi, P.Donati, D.

(2014) Bioorg Med Chem 22: 4998

  • DOI: https://doi.org/10.1016/j.bmc.2014.06.025
  • Primary Citation Related Structures: 
    4D0W, 4D0X, 4D1S

  • PubMed Abstract: 

    We report herein the discovery, structure guided design, synthesis and biological evaluation of a novel class of JAK2 inhibitors. Optimization of the series led to the identification of the potent and orally bioavailable JAK2 inhibitor 28 (NMS-P953). Compound 28 displayed significant tumour growth inhibition in SET-2 xenograft tumour model, with a mechanism of action confirmed in vivo by typical modulation of known biomarkers, and with a favourable pharmacokinetic and safety profile.


  • Organizational Affiliation
    • Nerviano Medical Sciences S.r.l., Oncology, Viale Pasteur 10, 20014 Nerviano (MI), Italy. Electronic address: gabriella.brasca@nervianoms.com.

Macromolecule Content 

  • Total Structure Weight: 35.67 kDa 
  • Atom Count: 2,700 
  • Modeled Residue Count: 293 
  • Deposited Residue Count: 298 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
TYROSINE-PROTEIN KINASE JAK2298Homo sapiensMutation(s): 0 
EC: 2.7.10.2
UniProt & NIH Common Fund Data Resources
Find proteins for O60674 (Homo sapiens)
Explore O60674 
Go to UniProtKB:  O60674
PHAROS:  O60674
GTEx:  ENSG00000096968 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupO60674
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
953

Query on 953



Download:Ideal Coordinates CCD File
B [auth A]5-(2-aminopyrimidin-4-yl)-2-[2-chloro-5-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide
C16 H11 Cl F3 N5 O
CZUQYAXYBOEHCY-UHFFFAOYSA-N
GOL

Query on GOL



Download:Ideal Coordinates CCD File
C [auth A]GLYCEROL
C3 H8 O3
PEDCQBHIVMGVHV-UHFFFAOYSA-N
Modified Residues  1 Unique
IDChains TypeFormula2D DiagramParent
PTR
Query on PTR
A
L-PEPTIDE LINKINGC9 H12 N O6 PTYR

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.82 Å
  • R-Value Free:  0.219 (Depositor), 0.215 (DCC) 
  • R-Value Work:  0.163 (Depositor), 0.162 (DCC) 
  • R-Value Observed: 0.166 (Depositor) 
Space Group: C 2 2 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 93.07α = 90
b = 101.76β = 90
c = 67.71γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
SCALEPACKdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Revision History  (Full details and data files)

  • Version 1.0: 2014-07-23
    Type: Initial release
  • Version 1.1: 2014-09-10
    Changes: Database references
  • Version 1.2: 2017-09-27
    Changes: Data collection
  • Version 1.3: 2019-03-06
    Changes: Data collection, Derived calculations, Experimental preparation
  • Version 1.4: 2019-04-24
    Changes: Data collection, Source and taxonomy
  • Version 1.5: 2023-12-20
    Changes: Data collection, Database references, Derived calculations, Other, Refinement description
  • Version 1.6: 2024-11-06
    Changes: Structure summary